Background Chronic obstructive pulmonary disease (COPD) is characterized by chronic airflow limitation. The prevalence of airflow limitation in Japan is 10.9% (16.4% of males and 5.0% of females). Cigarette smoking is well known as a major cause of COPD. However, few epidemiological studies have evaluated the effects of cigarette smoking on pulmonary function in healthy subjects. Methods Subjects aged 40 years or older (n=2,917), who had participated in a community-based annual health check in Takahata, Japan, from 2004 through 2005, were enrolled in the study. The smoking histories of these subjects were investigated using a self-reported questionnaire. Forced vital capacity (FVC), forced expiratory volume in 1 second (FEV1), and forced expiratory flow at 25-75% of FVC (FEF25-75) were measured by standard procedures using spirometric machines. Results There were 554 current smokers (18.6%) and 403 former smokers (13.8%). The prevalence of airflow limitation defined by FEV1/FVC <0.7 in this population was 10.6%, and prevalence of airflow limitation defined by 5th percentile lower limit of normal was 6.4%. In smokers, percent predicted values of measured spirometric parameters (%FVC, %FEV1 and %FEF25-75) decreased significantly with age, except for male %FVC. Also, percent predicted values of measured spirometric parameters decreased significantly with increasing pack-years, except for female %FEF25-75. Conclusion Cigarette smoking increased the prevalence and severity of airflow limitation. It is concluded that cigarette smoking increases the risk of airflow limitation in a healthy Japanese population.
Introduction
Chronic obstructive pulmonary disease (COPD) is a preventable and treatable disease, with significant extrapulmonary effects that may contribute to severity in individual patients (1) . The pulmonary component of COPD is characterized by airflow limitation that is not fully reversible. The airflow limitation is usually progressive and is associated with an abnormal inflammatory response of the lung to noxious particles and gases. Worldwide, cigarette smoking is the most common risk factor for COPD, although in many Department of Cardiology, Pulmonology, and Nephrology, Yamagata University School of Medicine, Yamagata, Department of Gastroenterology, Yamagata University School of Medicine, Yamagata and Department of Neurology, Hematology, Metabolism, Endocrinology, and Diabetology, Yamagata University School of Medicine, Yamagatacountries, air pollution resulting from the burning of wood and other biomass fuels has been identified as an additional risk factor for COPD (2, 3) .
Spirometry is a useful tool to diagnose and evaluate the severity of respiratory disease. A forced vital capacity (FVC) maneuver can be used to evaluate the condition of the airways. Vital capacity (VC) and forced expiratory volume in 1 second (FEV1) are clinical markers for respiratory disease. A percent predicted VC (%VC) value of less than 80% indicates restrictive disease of the lung, while a FEV1/FVC ratio of less than 70% is indicative of airflow limitation (4) . Also, forced expiratory flow at 25-75% of FVC (FEF25-75) is known to be a parameter which correlates well with the total amount of inhaled cigarette smoke in patients with COPD (5, 6) . In these patients, age and the initial value of FEV1 were the most reliable predictors of death (7) . Therefore, it is necessary to perform pulmonary function tests in order to diagnose and treat COPD. However, pulmonary function testing is not widely performed even for current heavy smokers, and many COPD patients remain undiagnosed (8) (9) (10) (11) (12) (13) .
The prevalence of airflow limitation in Japanese people aged 40 years or older is reported to be 10.9% (16.4% of males and 5.0% of females) (14) . Cigarette smoking is well known to be a major cause of COPD. However, there are only a few reports of cohort studies that have evaluated the impact of cigarette smoking on airflow limitation (15) (16) (17) . In this study, we evaluated the pulmonary function tests of Japanese individuals who participated in a community-based annual health check in Takahata, Yamagata. Predictive equations for FVC, FEV1 and FEF25-75 were derived from never smoking subjects in this study. Age-related changes in % FVC, percent predicted FEV1 (%FEV1) and percent predicted FEF25-75 (%FEF25-75) were cross-sectionally compared between non-smokers and smokers, in order to perform an epidemiological assessment of the effect of cigarette smoking on pulmonary function.
Methods

Study population
This study formed part of the Molecular Epidemiological Study utilizing the Regional Characteristics of 21st Century Centers of Excellence (COE) Program and the Global COE Program in Japan. Details of the study methodology have been described elsewhere (18) . The study was approved by the institutional ethics committee and all participants gave written informed consent.
This study utilized a community-based annual health check, in which all inhabitants of Takahata town (total population 26,026) in northern Japan, who were aged 40 years or older, were invited to participate. This region has a resident population of 15,222 adults aged 40 years or older (7,109 males and 8,113 females). From June 2004 through November 2005, 1,380 males and 1,735 females (total 3,165) participated in the program and agreed to enroll in the study. However, due to incomplete data 248 subjects were excluded from the analysis. Data for a total of 2,917 subjects (1,325 males, 1,592 females) was entered into the final statistical analysis.
Subjects used a self-reported questionnaire to document their medical histories, current medications and clinical symptoms. Current, former or never smokers were categorized according to the responses on the self-reported questionnaire. Subjects who categorized themselves as "never smokers" despite indicating the number of cigarettes smoked per day or the number of years of smoking were categorized as "former smokers".
Lung function measurements
FVC, FEV1 and FEF25-75 were measured using standard spirometric techniques, with subjects performing FVC maneuvers on a CHESTAC-25 part II EX instrument (Chest Corp., Tokyo, Japan) under guideline of the Japanese Respiratory Society (JRS) (19) . Bronchodilator was not administered prior to measurements. The highest value from at least three FVC maneuvers by each subject was used for the analysis. Two pulmonary physicians assessed the results of flow-volume curves by visual inspection, and they excluded subjects with poor studied data according to JRS criteria (19) .
Subjects with an FEV1/FVC ratio <70% were classified as having airflow limitation. The severity of airflow limitation was stratified by %FEV1 in accordance with the criteria specified by the Global Initiative for Chronic Obstructive Lung Disease (GOLD): %FEV1 "80, mild; 50 ! %FEV1 <80, moderate; 30 ! %FEV1 <50, severe; %FEV1 <30, very severe (1). Inconsistent with GOLD guideline (1), American Thoracic Society (ATS) and European Respiratory Society (ERS) recommend using 5th percentile lower limit of normal (LLN) as cutoff value for the definition of airflow obstruction (20, 21) . We obtained predictive equation of FEV1/ FVC from this study population, and determined the equation which calculates the LLN of the subject; 5th percentile LLN of FEV1/FVC = prediction -1.645 × standard error of estimate (SEE) (22, 23) .
Statistical analysis
Student's t test was used to evaluate differences in means, and chi-square tests were used to evaluate differences in proportions. The non-parametric Mann-Whitney U test and Kruskal-Wallis test were used to compare variables that were not normally distributed. Data are expressed as mean ± SD. Predictive equations for FVC, FEV1, and FEF25-75 were established by multiple linear, backward step-wise, regression. The difference of slopes in regressions was compared by analysis of covariance (ANCOVA) between never-smoker and former/current-smoker. All statistical analyses were performed using JMP version 7.0.2 software (SAS Institute Inc., Cary, NC, USA). Statistical significance was defined as p<0.05.
T a b l e 1 . Co mp a r i s o n o f t h e B a s e l i n e Ch a r a c t e r i s t i c s b e t we e n Me n a n d Wo me n 
Results
Baseline characteristics of the participants
The baseline characteristics of the 2,917 subjects whose data was entered into final analysis are shown in Table 1 . The mean age was 62.8 years, and there were 554 current smokers (18.6%) and 403 former smokers (13.8%). The proportion of smokers was higher among males than females. 2.2% subjects had medical history of pulmonary diseases (male: 3.5%, female: 1.1%). However, the rate of prior diagnosed bronchial asthma or COPD patients in this population was unknown, because the self-reported questionnaire did not ask the detail of pulmonary diseases.
Age, gender, smoking history and pulmonary function
The relationships between age and the absolute values of FVC, FEV1 and FEF25-75 are demonstrated in Fig. 1 . Absolute values of FVC, FEV1 and FEF25-75 declined with age in both never-smokers and former/current-smokers. However, the rates of decline of FEV1 and FEF25-75 in males, and FVC, FEV1 and FEF25-75 in females were significantly greater in the former/current-smoker group than in the never-smoker group. In contrast, the difference in the rates of decline in FVC between smoking and non-smoking male subjects did not reach statistical significance.
Because absolute values of FVC, FEV1 and FEF25-75 were not adjusted for age or body size of the subjects, we attempted to compare the age-related changes in FVC, FEV1 and FEF25-75 using standardized values for these parameters. Predictive equations for reference values of FVC, FEV1 and FEF25-75 based on the age, height (HT) and body weight (BW) of the subject were derived from never-smoking subjects by backward stepwise, multiple linear regression analysis ( Table 2 ). The equations for the spirometric parameters derived from this study are indicated in Table 2 . The equations for FVC and FEV1 were correlated with those of JRS (24) Predictive equations for FVC, FEV1 and FEF25-75 were also derived for male smoking subjects, using backward stepwise, multiple linear regression analysis. However, it was not possible to derive equations for female smokers due to the small number of these subjects. The equations for male smokers were: FVC (male smoker) = - 
Prevalence of airflow limitation
The data for the prevalence of airflow limitation defined by FEV1/FVC <0.7 (AFL0.7) is summarized in Fig. 2 , Tables 3 and 4. Figures 2A & 2B show the relationship between FEV1/FVC and %FEV1. 4.6% subjects with AFL0.7 had medical history of pulmonary diseases (male: 6.1%, female: 1.1%).The prevalence of airflow limitation was higher in male subjects than in female subjects (Figs. 2C & 2D; chi-square test: likelihood ratio = 82.58, degree of freedom =1, p<0.001). In male subjects with AFL0.7 in former/current smoking group were more prevalent than in never smoking group (Table 3 ). In contrast, female subjects with AFL0.7 in former/current smoking group were similar to in never smoking group (Table 3 ). The prevalence of AFL0.7 also increased with increasing age (Figs. 2E, 2F and Table 4 ). While the prevalence of AFL0.7 in male subjects aged 4th and 5th decades did not differ between never smoker and former/current smoker, the prevalence of AFL0.7 in male former/current smoking subjects aged 6th decade and over was significantly higher than in never smoking subjects (Table 4). In female, the prevalence of AFL0.7 in former/current smoker was only significantly higher than in never smoking subjects in the group aged 70 and over (Table 4 ). The unadjusted prevalence of AFL0.7 in the total study population was 
F i g u r e 1 . Ag e -r e l a t e d c h a n g e s i n s p i r o me t r i c p a r a me t e r s i n t h e T a k a h a t a p o p u l a t i o n . Gr a p h s s h o w t h e r e l a t i o n s h i p s b e t we e n a g e a n d F VC ( A, ma l e s ; B , f e ma l e s ) , F E V1 ( C, ma l e s ; D, f e ma l e s ) a n d F E F 2 5 -7 5 ( E , ma l e s ; F , f e ma l e s ) . Op e n c i r c l e s i n d i c a t e n e v e r s mo k e r s a n d c l o s e d c i r c l e s , f o r me r / c u r r e n t s mo k e r s . Da s h e d l i n e i n d i c a t e s t h e r e g r e s s i o n f o r n e v e r s mo k e r s a n d s o l i d l i n e , t h e r e g r e s s i o n f o r f o r me r / c u r r e n t s mo k e r s . T h e d i f f e r e n c e i n t h e s l o p e s o f t h e r e g r e s s i o n l i n e s b e t we e n n e v e r -s mo k e r s a n d f o r me r / c u r r e n t -s mo k e r s wa s c o mp a r e d b y a n a l y s i s o f c o v a r i a n c e ( ANCOVA) , a s i n d i c a t e d i n t h e i n s e t . S p i r o me t r i c p a r a me t e r s d e c l i n e d s i g n i f i c a n t l y wi t h a g e i n s mo k e r s c o mp a r e d wi t h n e v e r -s mo k e r s , e x c e p t f o r F VC i n ma l e s .
10.6%. The proportions of mild, moderate, severe and very severe airflow limitation, as categorized according to the GOLD criteria, were 42.2%, 46.4%, 10.4% and 1.0%, respectively, in this population. In addition, airflow limitation was more severe in male subjects than in female subjects (Figs. 2C-2F; chi-square test: likelihood ratio = 84.82, degree of freedom = 4, p<0.001; ordered logistic regression analysis: likelihood ratio = 84.24, degree of freedom = 1, p< 0.001). ATS and ERS recommend using 5th percentile LLN value for diagnosing COPD instead of fixed value of FEV1/FVC < 0.7 (20, 21) . The prevalence of airflow limitation defined by LLN value (AFLLLN) is summarized in Table 5 . Overall prevalence of AFLLLN was 6.4% in this population (male: 8.0%, female: 5.1%). In never smoker, the prevalence of AFLLLN was 4.7% (male: 4.7%, female: 4.7%). In former/ T a b l e 2 . B a c k wa r d S t e p wi s e , Mu l t i p l e L i n current smoker, it was 9.9% (male: 10.1%, female: 8.9%). In people aged 6th and 7th decades, the prevalence of AFLLLN in former/current smoker was significantly higher than in never smoker.
f S p i r o me t r i c P a r a me t e r s
Relative risk of airflow limitation
The relative risk of airflow limitation increased with increasing age, male gender, a history of habitual smoking, and increasing pack-years of smoking ( Table 6 ).
The effects of age and amount of inhaled cigarette smoke on pulmonary function
Using predictive values of spirometric measures obtained from this population, we showed the relationship of age with %FVC (Figs. 3A, 3B ), % FEV1 (Figs. 3C, 3D ) and % FEF25-75 (Figs. 3E, 3F ), in never-smokers and former/currentsmokers. In female former/current-smoking subjects, %FVC (Fig. 3B), %FEV1 (Fig. 3D ) and %FEF25-75 (Fig. 3F) declined significantly with age, compared with never smoking subjects. %FEV1 (Fig. 3C ) and %FEF25-75 (Fig. 3E ) declined significantly with age in male former/current-smoking subjects. In contrast, the difference in the rates of decline of % FVC between male former/current-smokers and male neversmokers did not reach statistical significance (Fig. 3A) .
The association between the declines in %FVC, %FEV1 and %FEF25-75, and amount of inhaled cigarette smoke (packyears) were assessed. In male subjects, %FVC, %FEV1 and %FEF25-75 declined significantly with increasing pack-years (Figs. 4A, 4C, & 4E) . In female subjects, %FVC and %FEV1 declined significantly with increasing pack-years (Figs. 4B & 4D) , whereas %FEF25-75 did not change with increasing pack-years (Fig. 4F ).
Discussion
In this paper, predictive equations for FVC, FEV1 and FEF25-75 were derived for Japanese never-smokers aged 40 years or older, living in Takahata town, and who participated in an annual health check. Previously, JRS provides reference values for FVC and FEV1 (24) , and there were good correlations between the JRS reference values and those derived in the present study. This suggests that the data obtained in the present study was reliable and that the findings are applicable to the general Japanese population. Using these predictive values, cross-sectional comparisons of agerelated changes in %FVC, %FEV1 and %FEF25-75 between smokers and never-smokers were then performed. In neversmoking subjects, %FVC, %FEV1 and %FEF25-75 did not change with age. In contrast, %FEV1 and %FEF25-75, which are both indicators of airflow limitation, declined significantly with age in smoking subjects. Furthermore, %FEV1 declined significantly with increasing number of pack-years smoked. Therefore, this epidemiological study has strongly suggested that long-term inhalation of cigarette smoke damages the airways of smokers.
F i g u r e 2 . P r e v a l e n c e a n d s e v e r i t y o f a i r f l o w l i mi t a t i o n i n t h e T a k a h a t a p o p u l a t i o n . Gr a p h s s h o w r e l a t i o n s h i p s b e t we e n F E V1 / F VC a n d %F E V1 i n ma l e s ( A) a n d f e ma l e s ( B ) . T h e s y mb o l s i n t h e a r e a o f l e s s t h a n 7 0 % f o r F E V1 / F VC i n d i c a t e i n d i v i d u a l s wi t h a i r f l o w l i mi t a t i o n . Amo n g t h e s e i n d i v i d u a l s , t h e s e v e r i t y o f a i r f l o w l i mi t a t i o n wa s s t r a t i f i e d a c c o r d i n g t o t h e GOL D c r i t e r i a : mi l d : %F E V1 ≥ 8 0 %, mo d e r a t e : 5 0 % ≤ %F E V1 < 8 0 %, s e v e r e : 3 0 % ≤ %F E V1 < 5 0 %, a n d v e r y s e v e r e : %F E V1 < 3 0 %. T h e p r o p o r t i o n o f s u b j e c t s i n e a c h c a t e g o r y o f s e v e r i t y o f a i r f l o w l i mi t a t i o n i s i n d i c a t e d f o r ma l e s ( C) a n d f e ma l e s ( D) . T h e d e t a i l s o f s e v e r i t y o f a i r f l o w l i mi t a t i o n i n e a c h a g e g r o u p , f o r ma l e s ( E ) a n d f e ma l e s ( F ) a r e a l s o i n d i c a t e d . T h e p r e v a l e n c e o f a i r f l o w l i mi t a t i o n wa s h i g h e r a mo n g ma l e s u b j e c t s ( C) t h a n f e ma l e s u b j e c t s ( D) . T h e p r e v a l e n c e o f a i r f l o w l i mi t a t i o n a l s o i n c r e a s e d wi t h i n c r e a s i n g a g e ( E & F ) .
In this paper, the prevalence of AFLLLN was demonstrated (Table 5 ). As shown in Table 4 , the prevalence of AFL0.7 in never smoker increased with increasing age. Thus, using the fixed value of FEV1/FVC <0.7 is questionable for examining the existence of airflow limitation in older subjects, because it ignores the natural age-related change of lung function. Application of LLN value for examining the existence of airflow limitation is thought to be able to avoid overdiagnosing the presence of airflow limitation in old subjects, and underdiagnosing the presence of airflow limitation in young subjects (22, 23) . While the prevalence of AFL0.7 in never
T a b l e 3 . Co mp a r i s o n o f t h e De g r e e o f Ai r f l o w L i mi t a t i o n b e t we e n
Ne v e r S mo k e r a n d F o r me r / Cu r r e n t S mo k e r In male subjects, the proportion of air flow limitation was significantly different between never smoker and former/current smoker (chi-square test, p <0.0001).
In female subjects, the proportion of air flow limitation was not significantly different between never smoker and former/current smoker (chi-square test, p =0.832). smoking subjects aged 6th and 7th decades was over 10%, the prevalence of AFLLLN in never smoker was less than 8% (Tables 4 & 5) . Importantly, the prevalence of AFLLLN in smoking subjects aged 6th and 7th decades was significantly higher than in never smokers (Table 5 ). In addition, three female subjects in 4th and 5th decade were underdiagnosed as "no airflow limitation" by the criteria using FEV1/FVC <0.7 (Tables 4 & 5 Co mp a r i s o n o f t h e P r e v a l e n c e o f Ai r f l o w L i mi t a t i o n De f i n e d b y L o we r L i mi t o f No r ma l Va l u e b e t we e n Ne v e r S mo k e r a n d F o r me r / Cu r r e n t S mo k e r i n E a c h Ge n e r a t i o n Data was analyzed using chi-square tests.
T a b l e 4 . Co mp a r i s o n o f t h e De g r e e o f Ai r f l o w L i mi t a t i o n b e t we e n Ne v e r S mo k e r a n d F o r me r / Cu r r e n t S mo k e r i n E a c h Ge n e r a t i o n
T a b l e 6 . Re l a t i v e Ri s k o f Ai r f l o w L i mi t a t i o n
* Because of incomplete questionnaire report regarding the pack years of smoking, 344 subjects were excluded from the analyses.
Epidemiology study (NICE) (14) . They randomly contacted individuals from the telephone directory, and invited them to attend the clinic for pulmonary function testing. A total of 2,343 healthy individuals were enrolled, and the prevalence F i g u r e 3 . Ag e -r e l a t e d c h a n g e s i n s t a
n d a r d i z e d s p i r o me t r i c p a r a me t e r s i n t h e T a k a h a t aF i g u r e 4 . T h e e f f e c t o f c i g a r e t t e s mo k i n g o n s t a n d a r d i z e d s p i r o me t r i c p a r a me t e r s i n s u b j e c t s i n t h e T a k a h a t a p o p u l a t i o n . Gr a p h s s h o w t h e r e l a t i o n s h i p s b e t we e n s t a n d a r d i z e d s p i r o me t r i c p a -
r a me t e r s a n d p a c k -y e a r s o f s mo k i n g . %F VC ( A: ma l e s a n d B : f e ma l e s ) a n d %F E V1 ( C: ma l e s a n d D: f e ma l e s ) we r e s i g n i f i c a n t l y c o r r e l a t e d wi t h p a c k -y e a r s . %F E F 2 5 -7 5 wa s s i g n i f i c a n t l y c o r r e l a t e d wi t h p a c k -y e a r s i n ma l e s u b j e c t s ( E ) , b u t n o t i n f e ma l e s u b j e c t s ( F ) . exposed to cigarette smoke compared with populations living in other areas of Japan. Takahata town has an aging population, and therefore the age-distribution in the present study also differed from that of the NICE study (Table 3) . Since the prevalence of airflow limitation is higher in older persons, this is a possible explanation for the differences in the severity of airflow limitation between subjects in the NICE study and those in the present study. This explanation is partly supported by the report by Omori et al (11) . They demonstrated the prevalence of AFL0.7 on "hospital-based" medical check-up in Japanese subjects aged 40-69, and demonstrated the severity of airflow limitation between smokers and nonsmokers according to the age decade of the subjects, whereas NICE study lacked this analysis. The proportion of moderate airflow limitation in smokers increased with increasing decades of subjects in their paper, although the proportion of mild airflow limitation in smokers was still the highest in the subjects aged 60-69 (11). The annual rate of decline in FEV1 in the Japanese population can be estimated from the equation for FEV1 derived in the present study. In never-smokers, the estimated annual rate of decline in FEV1 was 28 mL for males and 20 mL for females, while in male former/current smokers it was 37 mL. Fletcher and Peto investigated the effect of cigarette smoking on the decline in FEV1 in male workers in London (15) . Recently, analysis of data from the Framingham Offspring Cohort also demonstrated that the decline in FEV1 was more rapid in smokers than in never-smokers (16) . To date, no epidemiological analysis has been performed on the impact of cigarette smoking on pulmonary function in the Japanese population. This is the first study to demonstrate the decline in pulmonary function (FEV1, as well as FVC and FEF25-75) in Japanese subjects, by statistical analysis of data from spirometric measurements performed as part of a community-based annual health check.
There are a couple of limitations to this study. Selfreported questionnaires may not always provide accurate data, due to misunderstanding of the questionnaire or failure to accurately recall smoking histories. The questionnaire asked the existence of "history of pulmonary diseases" and "current therapy for pulmonary disease", but did not ask the details. Thus, the prevalence of bronchial asthma or medication for the disease was not revealed in this questionnaire. In addition, because the cigarette smoking rate in Japanese females was low, the number of female subjects enrolled in this study was only 135 (Table 1) . However, despite these limitations, the study clearly demonstrated the impact of cigarette smoking on pulmonary function in a Japanese population.
In conclusion, cigarette smoking enhances the prevalence of airflow limitation. Cigarette smoking was also shown to be a factor that correlated with the decline in %FEV1 in both males and females. The present study clearly demonstrated that long-term cigarette smoking increases the risk of airflow limitation in healthy individuals. The findings from this epidemiological study have demonstrated that early cessation of smoking is necessary in order to prevent the development of COPD among smokers.
